Home › Non-Hodgkinlymfoom › North Carolina › Durham
Non-Hodgkinlymfoom klinische studies in Durham, NC
16 studies voor Non-Hodgkinlymfoom zoeken deelnemers op locaties in en rond Durham (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruterenFase 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mijl verwijderd
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruterenFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mijl verwijderd
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RekruterenObservatieonderzoek
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekruterenFase 3
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
RekruterenFase 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruterenObservatieonderzoek
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mijl verwijderd
Registry of Older Patients With Cancer
RekruterenObservatieonderzoek
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mijl verwijderd
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
RekruterenFase 1
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruterenFase 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
RekruterenFase 4
- Duke University Medical Center, Durham
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
RekruterenFase 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
RekruterenFase 1
- Duke University, Durham
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
RekruterenFase 1
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mijl verwijderd
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RekruterenObservatieonderzoek
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mijl verwijderd
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruterenFase 1
- University of North Carolina, Chapel Hill · 10 mijl verwijderd
Non-Hodgkinlymfoom studies in andere steden
- New York City, NY31 studies
- Houston, TX31 studies
- Boston, MA26 studies
- Nashville, TN21 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Washington, DC18 studies
- Milwaukee, WI18 studies
- Chicago, IL18 studies
- Atlanta, GA18 studies
- Columbus, OH18 studies
- Dallas, TX17 studies
Andere studies in Durham
- Borstkanker64 studies
- Kanker (alle vormen)58 studies
- Niet-kleincellige longkanker39 studies
- Multipel myeloom37 studies
- Acute myeloïde leukemie33 studies
- Metastatische kanker33 studies
- Prostaatkanker32 studies
- Longkanker32 studies
- Colorectale kanker28 studies
- Eierstokkanker27 studies
- Chronische lymfatische leukemie27 studies
- Hartfalen26 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.